Wu S - Search Results

1

Preoperative CT-based peritumoral and tumoral radiomic features prediction for tumor spread through air spaces in clinical stage I lung adenocarcinoma.

Liao G, Huang L, Wu S, Zhang P, Xie D, Yao L, Zhang Z, Yao S, Shanshan L, Wang S, Wang G, Wing-Chi Chan L, Zhou H. Liao G, et al. Among authors: wu s. Lung Cancer. 2022 Jan;163:87-95. doi: 10.1016/j.lungcan.2021.11.017. Epub 2021 Dec 6. Lung Cancer. 2022. PMID: 34942493 Free article.

2

A cascade dual-targeted nanocarrier for enhanced alectinib delivery to ALK-positive lung cancer.

Zeng F , Xu B , Zhu H , Wu S , Liao G , Xie D , Huang L , Qiao G , Yang X , Zhou H . Zeng F , et al. Among authors: wu s. Biomater Sci. 2020 Nov 21;8(22):6404-6413. doi: 10.1039/d0bm00970a. Epub 2020 Oct 13. Biomater Sci. 2020. PMID: 33047769

3

KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials.

Zhu H, Xie D, Yu Y, Yao L, Xu B, Huang L, Wu S, Li F, Zheng Y, Liu X, Xie W, Huang M, Li H, Zheng S, Zhang D, Qiao G, Chan LWC, Zhou H. Zhu H, et al. Among authors: wu s. Front Oncol. 2021 Jul 26;11:659200. doi: 10.3389/fonc.2021.659200. eCollection 2021. Front Oncol. 2021. PMID: 34381706 Free PMC article.

4

Development and validation of a preoperative CT-based radiomic nomogram to predict pathology invasiveness in patients with a solitary pulmonary nodule: a machine learning approach, multicenter, diagnostic study.

Huang L, Lin W, Xie D, Yu Y, Cao H, Liao G, Wu S, Yao L, Wang Z, Wang M, Wang S, Wang G, Zhang D, Yao S, He Z, Cho WC, Chen D, Zhang Z, Li W, Qiao G, Chan LW, Zhou H. Huang L, et al. Among authors: wu s. Eur Radiol. 2022 Mar;32(3):1983-1996. doi: 10.1007/s00330-021-08268-z. Epub 2021 Oct 16. Eur Radiol. 2022. PMID: 34654966 Free PMC article. Clinical Trial.

5

Identification of Prognostic Model Based on Immune-Related LncRNAs in Stage I-III Non-Small Cell Lung Cancer.

Li Q, Yao L, Lin Z, Li F, Xie D, Li C, Zhan W, Lin W, Huang L, Wu S, Zhou H. Li Q, et al. Among authors: wu s. Front Oncol. 2021 Oct 20;11:706616. doi: 10.3389/fonc.2021.706616. eCollection 2021. Front Oncol. 2021. PMID: 34745939 Free PMC article.

6

Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinoma.

Li Q, Xie D, Yao L, Qiu H, You P, Deng J, Li C, Zhan W, Weng M, Wu S, Li F, Zhou Y, Zeng F, Zheng Y, Zhou H. Li Q, et al. Among authors: wu s. Front Immunol. 2022 Sep 13;13:944378. doi: 10.3389/fimmu.2022.944378. eCollection 2022. Front Immunol. 2022. PMID: 36177001 Free PMC article.

7

A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy.

Xu B, Zeng F, Deng J, Yao L, Liu S, Hou H, Huang Y, Zhu H, Wu S, Li Q, Zhan W, Qiu H, Wang H, Li Y, Yang X, Cao Z, Zhang Y, Zhou H. Xu B, et al. Among authors: wu s. Bioact Mater. 2023 Apr 19;27:337-347. doi: 10.1016/j.bioactmat.2023.04.005. eCollection 2023 Sep. Bioact Mater. 2023. PMID: 37122898 Free PMC article.

8

Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB-IV NSCLC (LCDigital-IO Study): a multicenter retrospective study.

Wu S, Zhan W, Liu L, Xie D, Yao L, Yao H, Liao G, Huang L, Zhou Y, You P, Huang Z, Li Q, Xu B, Wang S, Wang G, Zhang DK, Qiao G, Chan LW, Lanuti M, Zhou H. Wu S, et al. J Immunother Cancer. 2023 Oct;11(10):e007369. doi: 10.1136/jitc-2023-007369. J Immunother Cancer. 2023. PMID: 37865396 Free PMC article.

9

C9orf72-Associated Dipeptide Repeat Expansions Perturb ER-Golgi Vesicular Trafficking, Inducing Golgi Fragmentation and ER Stress, in ALS/FTD.

Sultana J, Ragagnin AMG, Parakh S, Saravanabavan S, Soo KY, Vidal M, Jagaraj CJ, Ding K, Wu S, Shadfar S, Don EK, Deva A, Nicholson G, Rowe DB, Blair I, Yang S, Atkin JD. Sultana J, et al. Among authors: wu s. Mol Neurobiol. 2024 May 9. doi: 10.1007/s12035-024-04187-4. Online ahead of print. Mol Neurobiol. 2024. PMID: 38722513

10

A Multifunctional Nanoreactor-Induced Dual Inhibition of HSP70 Strategy for Enhancing Mild Photothermal/Chemodynamic Synergistic Tumor Therapy.

Wu S, Gao M, Chen L, Wang Y, Zheng X, Zhang B, Li J, Zhang XD, Dai R, Zheng Z, Zhang R. Wu S, et al. Adv Healthc Mater. 2024 May 9:e2400819. doi: 10.1002/adhm.202400819. Online ahead of print. Adv Healthc Mater. 2024. PMID: 38722289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37,190 results

Search Page